Cancer News and Research

Latest Cancer News and Research

Implantable sensor technology and cartilage scaffolding systems for bone and joint repair

A group of biomedical engineering researchers have cited recent advances in implantable sensor technology and cartilage scaffolding systems as major developments in the use of engineered cartilage for bone and joint repair.

27 Jun 2012

Jin Shin Jyutsu improves side effects of cancer treatment

A new study by the University of Kentucky Markey Cancer Center shows that patients reported significant improvement in side effects of cancer treatment following just one Jin Shin Jyutsu session. Jin Shin Jyutsu is an ancient form of touch therapy similar to acupuncture in philosophy.

27 Jun 2012

Decline in preventive mammography rates after USPSTF recommendation

Preventive mammography rates in women in their 40s have dropped nearly 6 percent nationwide since the U.S. Preventive Services Task Force (USPSTF) recommended against routine mammograms for women in this age group, a Mayo Clinic analysis shows.

27 Jun 2012

Women & Infants Hospital of Rhode Island to participate in Best Fed Beginnings

Women & Infants Hospital of Rhode Island has been selected to participate in Best Fed Beginnings, a first-of-its-kind national effort to significantly improve breastfeeding rates in states where rates are currently the lowest. Rhode Island ranks 35th in the nation for breastfeeding initiation. Women & Infants is the only hospital in New England to be selected for this collaborative.

27 Jun 2012

New approach improves survival in patients with inoperable complex pancreatic adenocarcinoma

Investigators at the University of Texas MD Anderson Cancer Center, Houston, have reported on a new approach to treating previously inoperable complex pancreatic adenocarcinoma that has significantly increased long-term survival for some patients.

27 Jun 2012

New type of micromachine can penetrate tissue and overcome cellular barriers

Microscopically small submarines that can swim through our blood to clear out clogged arteries or destroy malignant tumors. This concept may sound utopian, but it isn’t. Various micro- and nanomachines have in fact already been developed.

27 Jun 2012

SIR/TAC combination more effective in preventing GVHD after allogeneic blood cell transplantation

Researchers at Moffitt Cancer Center have conducted a clinical trial aimed at preventing graft vs. host disease (GVHD) in patients who have received hematopoietic (blood) cell transplants (HCT). The study, comparing the drug tacrolimus (TAC) in combination with either methotrexate (MTX ) or sirolimus (SIR), found that the sirolimus/tacrolimus (SIR/TAC) combination was more effective in preventing grades II-IV acute GVHD and moderate-severe chronic GVHD after allogeneic blood cell transplantation.

27 Jun 2012

Scientists identify novel mechanism behind bacterial pathogenesis

Scientists have identified a new mechanism of bacterial pathogenesis. The results of the research project, partly funded by the Academy of Finland, have been published in the journal Proceedings of the National Academy of Sciences of the United States of America (PNAS).

27 Jun 2012

GUMC receives NIH grant to establish Center of Excellence for Health Disparities

The National Institute on Minority Health and Health Disparities, a part of the National Institutes of Health (NIH), has awarded a $6.1 million grant over the next five years to Georgetown University Medical Center to establish the Center of Excellence for Health Disparities in Our Nation's Capital.

27 Jun 2012

Study investigates how glucose metabolism affects biochemical signals in cancer cells

Compared to normal cells, cancer cells have a prodigious appetite for glucose, the result of a shift in cell metabolism known as aerobic glycolysis or the "Warburg effect." Researchers focusing on this effect as a possible target for cancer therapies have examined how biochemical signals present in cancer cells regulate the altered metabolic state.

27 Jun 2012

Top-line final data from Provectus’ PV-10 phase 2 trial on metastatic melanoma

Provectus Pharmaceuticals, Inc., a development-stage oncology and dermatology biopharmaceutical company, announced that top-line final data from its phase 2 clinical trial of PV-10 for metastatic melanoma were presented at the 2nd European Post-Chicago Melanoma Meeting 2012, Interdisciplinary Global Conference on Developing New Treatments for Melanoma, on June 22, 2012, in Munich, Germany.

27 Jun 2012

Study: Moderate coffee intake reduces risk of heart failure

While current American Heart Association heart failure prevention guidelines warn against habitual coffee consumption, some studies propose a protective benefit, and still others find no association at all. Amidst this conflicting information, research from Beth Israel Deaconess Medical Center attempts to shift the conversation from a definitive yes or no, to a question of how much.

27 Jun 2012

Prenatal exposure to BPA appears to program uterine estrogen responsiveness in adulthood

Prenatal exposure to bisphenol A, or BPA, a chemical found in many common plastic household items, can cause numerous genes in the uterus to respond differently to estrogen in adulthood, according to a study using a mouse model. The results will be presented Tuesday at The Endocrine Society's 94th Annual Meeting in Houston.

27 Jun 2012

Seahorse Bioscience launches XF Palmitate-BSA FAO Reagent for FAO assays

Seahorse Bioscience, the world leader in manufacturing instrumentation and assay kits for measuring cellular metabolism, has announced the launch of its newest product, the XF Palmitate-BSA FAO Reagent, eliminating the need for radioactivity in fatty acid oxidation (FAO) assays.

27 Jun 2012

Sunshine Biopharma completes Adva-27a cytotoxicity study on multidrug-resistant lung cancer

Sunshine Biopharma Inc., a pharmaceutical company focused on the research, development and commercialization of drugs for the treatment of various forms of cancer, today announced that it has completed a cytotoxicity study of its lead compound, Adva-27a, in H69AR, a Multidrug Resistant Small Cell Lung Cancer cell line. Cytotoxicity studies measure the ability of a drug to destroy cancer cells in vitro.

27 Jun 2012

Link between bacterial vaginosis and female-to-male HIV transmission risk

An investigation led by UCSF has found that the risk of female-to-male HIV transmission is increased three fold for women with bacterial vaginosis, a common disorder in which the normal balance of bacteria in the vagina is disrupted.

27 Jun 2012

Caltech researchers develop technique to focus light inside biological tissue

Imagine if doctors could perform surgery without ever having to cut through your skin. Or if they could diagnose cancer by seeing tumors inside the body with a procedure that is as simple as an ultrasound.

27 Jun 2012

Astellas submits enzalutamide MAA with EMA for treatment of CRPC

Today, Astellas Pharma Inc. announces the submission of a European marketing authorisation application to the European Medicines Agency (EMA) for enzalutamide for the treatment of men with metastatic castration-resistant prostate cancer who have been previously treated with docetaxel-based chemotherapy.

27 Jun 2012

New FIRS data reveals lack of understanding and concern among public about lung disease

New data released by the Forum of International Respiratory Societies (FIRS) to coincide with World Spirometry Day today has revealed a lack of understanding and concern among the public about the world's biggest killer - lung disease, which now claims the lives of almost 4 million people a year.

27 Jun 2012

MRI scans determine whether chemotherapy is working long before tumors shrink

Studies on some 55 U.S. men and women with potentially deadly liver or pancreatic cancers show that specialized MRI scans can tell within a month whether highly toxic chemotherapy is working and killing tumor cells long before tumors actually shrink – or fail to shrink.

26 Jun 2012

Cancer News and Research

Latest Cancer News and Research

Implantable sensor technology and cartilage scaffolding systems for bone and joint repair

Jin Shin Jyutsu improves side effects of cancer treatment

Decline in preventive mammography rates after USPSTF recommendation

Women & Infants Hospital of Rhode Island to participate in Best Fed Beginnings

New approach improves survival in patients with inoperable complex pancreatic adenocarcinoma

New type of micromachine can penetrate tissue and overcome cellular barriers

SIR/TAC combination more effective in preventing GVHD after allogeneic blood cell transplantation

Scientists identify novel mechanism behind bacterial pathogenesis

GUMC receives NIH grant to establish Center of Excellence for Health Disparities

Study investigates how glucose metabolism affects biochemical signals in cancer cells

Top-line final data from Provectus’ PV-10 phase 2 trial on metastatic melanoma

Study: Moderate coffee intake reduces risk of heart failure

Prenatal exposure to BPA appears to program uterine estrogen responsiveness in adulthood

Seahorse Bioscience launches XF Palmitate-BSA FAO Reagent for FAO assays

Sunshine Biopharma completes Adva-27a cytotoxicity study on multidrug-resistant lung cancer

Link between bacterial vaginosis and female-to-male HIV transmission risk

Caltech researchers develop technique to focus light inside biological tissue

Astellas submits enzalutamide MAA with EMA for treatment of CRPC

New FIRS data reveals lack of understanding and concern among public about lung disease

MRI scans determine whether chemotherapy is working long before tumors shrink

Understanding the DNA Damage Response in Innate Immunity eBook

Obesity, GLP-1s, and metabolic care

Automation in cell-based workflows

Data management challenges in scientific research

Cancer News and Research

Latest Cancer News and Research

Understanding the DNA Damage Response in Innate Immunity eBook

Obesity, GLP-1s, and metabolic care

Automation in cell-based workflows

Data management challenges in scientific research

Newsletters you may be interested in